Kite Pharma (Gilead Sciences)
Kite Pharma, now a subsidiary of Gilead, is a biotechnology company focused on curing cancer.
Spark Therapeutics was founded in 2013 and has access to over 2 decades of research and development from the Children's Hospital of Philadelphia.
Computer models could replace animal testing
A study suggests that advanced algorithms working from large chemical databases can predict a new chemical's toxicity better than standard animal tests. The computer-based approach could replace many animal tests commonly used during consumer product testing. It could also evaluate more chemicals than animal testing, a change that could lead to wider safety assessments.
3D printed membranes have faster water flow than conventional filters
A 3D-printing facility to manufacture a new type of water treatment membrane.
Unlike conventional membrane-manufacturing processes that use acids to make polymers porous that function as filters, Nano Sun 3D-prints millions of nanofibers layered on top of each other, compressed into a thin membrane.
Preparing for the surgical robot boom
With greater investment from healthcare organisations and surgical robot technology about to become generic, the conditions are perfect for a boom in the surgical robotics market. But how can design engineers and technical medical staff ensure these new systems operate reliably and safely?
RxFunction Inc, creators of walkasins, hires new CFO
Mary E. Anderson is the new Chief Financial Officer of RxFunction, Inc., a start-up medical device company that created walkasins® - the first Wearable Sensory Prosthesis (WSP™) - to help improve balance and gait in patients who experience balance problems due to sensory peripheral neuropathy.
MiraculeX are using plant proteins to make artificial sweeteners. Miraculin is one such protein, found in a berry native to West Africa.
Impossible Foods is developing technologies to produce non-animal based foods including meat and dairy products.
Medical start-up RxFunction Inc raises $7.5 million in Series A
Medical start-up RxFunction, Inc., a wearable technology company that created walkasins® - the first Wearable Sensory Prosthesis - has completed its Series A funding round, raising $7.5 million and surpassing the initial funding goal of $5 million.
Get immediate results with new blood test technology
Researchers have created a mobile version of the "Enzyme Linked Immunosorbent Assay" (ELISA), the gold standard technique used to detect the presence of an antibody or antigen. Instead of sending patients to a laboratory, new cell phone-based technology allows for the very same test to be conducted in the doctor's office, clinic or even in a remote area.
IDTechEx interviewed Aleksandr Shtukater, founder of Raayonnova, about their progress developing smart contact lenses integrating displays.
Trial of first bioelectronic device to treat rheumatoid arthritis
A pilot trial for patients with drug refractory rheumatoid arthritis in the U.S. The multi-center study, "A Randomized Controlled Study of the Safety and Efficacy of Neurostimula- tion Using a Vagus Nerve Stimulation Device in Patients with Rheumatoid Arthritis," assesses the safety and efficacy of a proprietary bioelectronic device in adult patients with RA who are not adequately responsive to multiple biologic agents.
Tissue Engineering and Regenerative Medicine
The aim of tissue engineering and regenerative medicine is to create living biological tissue that can repair and replace damaged tissues in the body, something that cannot be achieved by medicine and medical procedures.
Neuromodulation for migrane relief
electroCore, LLC has received clearance from the U.S. Food and Drug Administration for an expanded label for gammaCore as an acute treatment of pain associated with migraine in adult patients. gammaCore therapy is a proprietary, non-invasive neuromodulation treatment delivered by a hand-held unit that stimulates the vagus nerve through the skin.
CRISPR enhances cancer immunotherapy
Last year, the Food and Drug Administration approved the first cellular immunotherapies to treat cancer. These therapies involve collecting a patient's own immune cells -- called T cells -- and supercharging them to home in on and attack specific blood cancers, such as hard-to-treat acute lymphoblastic leukemia and non-Hodgkin lymphoma.
AI to help stroke victims
The U.S. Food and Drug Administration has granted a De Novo request for the first-ever Computer-Aided Triage and Notification Platform to identify Large Vessel Occlusion strokes in CTA imaging.
Human-on-a-Chip: using tissue engineering to replicate the human body
An application of tissue engineering that is rapidly growing is the building of organ-on-a-chip devices.